ArticleGlobalization and health2022
Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
Article in Globalization and health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 36 citations in OpenAlex.
- Economic factors promoting vaccine nationalism in the face of viral evolution.PLoS computational biology · 2026Article
- Mpox and the Ethics of Outbreak Management: Lessons for Future Public Health Crises.Developing world bioethics · 2026Article
- Solidarity and reciprocity during the COVID-19 pandemic: a longitudinal qualitative interview study from Germany.BMC public health · 2024Article
- Vaccine inequity: a threat to Africa's recovery from COVID-19.Tropical medicine and health · 2023Review
- Association between Gross National Income per capita and COVID-19 vaccination coverage: a global ecological study.BMC public health · 2023Article
- A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review.BMJ global health · 2023Article
- Africa (COVID-19) Vaccine Technology Transfer: Where Are We?Life (Basel, Switzerland) · 2023Review
- Policy responses to COVID-19: lessons for the global trade and investment regime.Globalization and health · 2023Article
- How can COVID-19 vaccines benefit people? A study based on the theory of the commons.Human vaccines & immunotherapeutics · 2023Article
- The ambiguous future of the COVID-19 pandemic in the presence of a vaccine.Health science reports · 2023Article
- Global health governance performance during Covid-19, what needs to be changed? a delphi survey study.Globalization and health · 2023Article
- Global vaccine equity? Reflections, lessons, and a way forward.New microbes and new infections · 2023Article
- Multi-Disciplinary Design and Implementation of a Mass Vaccination Clinic Mobile Application to Support Decision-Making.IEEE journal of translational engineering in health and medicine · 2023Article
- Correlates of support for international vaccine solidarity during the COVID-19 pandemic: Cross-sectional survey evidence from Germany.PloS one · 2023Article
- Trust is the common denominator for COVID-19 vaccine acceptance: A literature review.Vaccine: X · 2022Review
- Review
- Pandemic preparedness and response: exploring the role of universal health coverage within the global health security architecture.The Lancet. Global health · 2022Review
- Preparedness of South East Asia countries in view of monkeypox emergence: A call for action.The Lancet regional health. Southeast Asia · 2022Review
- Hijab or Niqab Interacts with Facemasks Usage at Healthcare Settings in Kabul, Afghanistan: A Multi-Center Observational Study.Healthcare (Basel, Switzerland) · 2022Article
- Access to the COVID-19 Vaccine.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 7 institutions in 7 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith large swathes of the world's population-majority clustered in low- and middle-income countries-still yet to receive the minimum of two doses of the COVID-19 vaccine; The need to address the failures of international solidarity to equitably distribute COVID-19 vaccines is now more urgent than ever to help curb the pandemic and prevent future variants. However, many high-income countries have adopted a "me first" approach, proceeding to offer COVID-19 booster doses to their entire populations, including those at least risk of severe illness, whilst the rest of the world is left unvaccinated or partially vaccinated with one dose for even their most vulnerable communities. MAIN BODY: COVID-19 vaccine inequity places the health of the global population at risk and exacerbates socio-economic repercussions, especially in low- and middle-income countries. Initiatives launched to combat vaccine inequity such as the Fair Allocation Framework for the COVID-19 Vaccines (COVAX) have been unsuccessful as several governments, primarily from high-income countries, have scaled down their contributions to the initiative. Furthermore, COVAX has not seriously engaged with the Access to COVID-19 Tools (ACT) Health Systems Connector, as was originally intended, leading to crucial health systems components critical to vaccine delivery to be overlooked. Several strategies can be employed to help achieve the desired global immunization goals, such as Intellectual Property waivers, increased donations, and activation of new COVID-19 vaccine manufacturing hubs. In addition, continued advocacy for vaccine equity by all involved and affected stakeholders, as well as critical amendments to existing or upcoming legislation and funding mechanisms will help address the shortcomings of current inequitable vaccine distribution.
conclusionsGlobal solidarity and collective action through pandemic governance mechanisms are urgently needed to ensure vaccine equity. These interventions are vital to rapidly mitigate ongoing health and humanitarian crises and ultimately curb the pandemic, sooner rather than later.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.